SAC Plea Hearing Today; Pharmas Oppose Deal

Nov 8 2013 | 11:41am ET

When U.S. District Judge Laura Swain Taylor weighs SAC Capital Advisors' plea deal today, some of the hedge funds' alleged victims want to be heard.

SAC is poised to plead guilty today to insider-trading—if, that is, Taylor approves the pact with prosecutors, which will see the hedge fund pay $1.2 billion and close to outside capital. Under the terms of that deal, it's a take-it-or-leave-it offer; if Taylor objects to any of its provisions, SAC will be permitted to withdraw its guilty plea on securities and wire fraud charges.

Some are hoping she simply rejects the agreement outright, including two pharmaceutical companies whose shares SAC traders allegedly dealt in illegally. Elan Corp. and Wyeth LLC asked Taylor to hear their objections at the hearing today; the two companies want Swain to junk the accord "because it allows SAC to plead guilty without admitting that it is guilty of the principal criminal conduct charges in the indictment—insider trading in the securities of Elan Corp. and Wyeth," the companies wrote yesterday.

SAC was not required to admit wrongdoing in those cases because the portfolio manager who made the trades, Mathew Martoma, has pleaded not guilty and is set to stand trial next year.

Elan and Wyeth are not alone in their opposition; U.S. District Judge Richard Sullivan, who on Wednesday signed off on the pact, asked people to stop e-mailing him about the matter.

Sullivan said he had received an e-mail Tuesday decrying the settlement as a "sweetheart deal" for SAC. Sullivan, who on Wednesday said that his own opinion was irrelevant and that he expected Taylor to make a more "searching inquiry" than his own, said that such views on the SAC case belong in letters to the editor or op-ed pieces and not in his inbox.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR